Focus: Lunaphore Technologies develops tissue analytics software and platforms for in vitro diagnostics across multiple therapeutic areas. The company operates from Switzerland with 160 active job openings, indicating significant scaling activity.
Profile data last refreshed 23h ago · AI intelligence enriched 2mo ago
Contracting — net -25 jobs in 30d
104 added, 129 removed. Active reduction in progress.
Lunaphore presents a growth-stage diagnostics opportunity with strong operational scaling, but lack of financial transparency and published data warrant due diligence before committing.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Lunaphore Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Lunaphore Technologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo